Skip to content

A Study Evaluating Oral-Health-Related Quality of Life and Treatment Patterns Among Dentin Hypersensitivity Sufferers

A Longitudinal Study Evaluating Oral-Health-Related Quality of Life and Treatment Patterns Among Dentin Hypersensitivity Sufferers in the Real World

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07337109
Enrollment
375
Registered
2026-01-13
Start date
2025-12-16
Completion date
2027-02-01
Last updated
2026-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dentin Hypersensitivity

Brief summary

The primary purpose of this study is to characterize changes in Oral-Health-Related Quality of Life (OHrQoL), as measured by the Dentin Hypersensitivity Experience Questionnaire (DHEQ) over a 12-month period.

Detailed description

This will be a longitudinal study investigating OHrQoL and treatment patterns amongst new sufferers of self-reported Dentin Hypersensitivity (DH). Over the 12-month study duration, 375 participants suffering from DH will complete questionnaires online once per month.

Interventions

None listed

Sponsors

HALEON
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Participant who has provided consent indicating they have been informed of all pertinent aspects of the study. * All genders who, at the time of screening, are aged more than or equal to (\>=)18 years. * Anyone who has begun to experience dentin hypersensitivity (self-reported) within the past three months. * Anyone who has started to use products to treat their tooth sensitivity within the past three months. * Participant who is able to independently complete all activities online. * Participants residing in the United States.

Exclusion criteria

* Anyone who has any chronic health conditions that could impact their participation in this study, such as cancer, mental health disorders, history of serious illness in the last three months, history of substance abuse, or planned surgery during the study period. * Participant whose sensitivity could be caused by other factors or clinical pathology than DH, as self-reported on the screening questionnaire, which include: 1. Anyone who suffers from tooth cavities, significant gum disease, cracked or fractured teeth, temporomandibular joint disease (TMD), or who has had tooth extractions or fillings within the last three months. 2. Anyone who wears braces (including Invisalign-like appliances) for treatment or dentures (full or partial). 3. Participant who has undergone treatment for periodontal or gum disease within 6 months of screening or is currently undergoing treatment for periodontal or gum disease. 4. Participant who has been informed by a Dental Health Care Professional (DHCP) that they have active periodontitis. 5. Participant who has been informed by a DHCP that they have active caries. 6. Participant with any chronic and/or severe painful health condition(s) which lead to regular use of pain relief medications (more than 3 days a week). * Anyone who has participated in another dentin hypersensitivity study within the last three months. * Currently participating in another research study or will be participating in any other research study at any point during this study's duration.

Design outcomes

Primary

MeasureTime frameDescription
Change From Baseline in Total DHEQ Score Over 12 MonthsBaseline and up to 12 MonthsChange from baseline in total DHEQ score and each of the domain scores (daily restrictions, coping behaviors, personal identity, social impact, emotional impact) over 12 months. The DHEQ has total 15 questions each will be scored on a scale ranging from 1 (strongly disagree) to 7 (strongly agree), thus total possible score will be ranging from 15 to 105, where higher score indicates worst outcome.

Secondary

MeasureTime frameDescription
Description of Treatment Selection Over 12 MonthsUp to 12 MonthsParticipants will select the appropriate options from the given list of products. Data will be summarized using descriptive statistics.
Treatment Discontinuation/Switch Over 12 MonthsUp to 12 MonthsParticipant will respond to the question either as Yes or No. Data will be summarized using descriptive statistics.
Frequency of Treatment Used Over 12 MonthsUp to 12 MonthsParticipants will select the appropriate frequency options from the given list. Data will be summarized using descriptive statistics.
Frequency of DH Over 12 MonthsUp to 12 MonthsParticipants will select the appropriate frequency options from the given list. Data will be summarized using descriptive statistics.
Frequency of Brushing at Baseline, Months 6 and 12Baseline, Months 6 and 12Participants will select the appropriate frequency options from the given list. Data will be summarized using descriptive statistics.

Countries

United States

Contacts

CONTACTHaleon Response Center
ww.clinical-trial-register@haleon.com+441932959500

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 29, 2026